These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38982307)

  • 1. The current landscape of coumarin hybrids with antibreast cancer therapeutic applications: An updated review.
    Wang R; Chen Z; Huang Y; Zhang Q; Chen M; Huang X
    Arch Pharm (Weinheim); 2024 Oct; 357(10):e2400438. PubMed ID: 38982307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coumarin Hybrids: Promising Scaffolds in the Treatment of Breast Cancer.
    Bhatia R; Rawal RK
    Mini Rev Med Chem; 2019; 19(17):1443-1458. PubMed ID: 30854961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coumarin-containing hybrids and their anticancer activities.
    Zhang L; Xu Z
    Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review.
    Wang G; Sun S; Wu B; Liu J
    Curr Top Med Chem; 2021; 21(19):1725-1736. PubMed ID: 33185162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current scenario of chalcone hybrids with antibreast cancer therapeutic applications.
    Wang H; Zhu J; Zhang Q; Tang J; Huang X
    Arch Pharm (Weinheim); 2024 May; 357(5):e2300640. PubMed ID: 38227398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives.
    Song F; Huo X; Guo Z
    Curr Top Med Chem; 2021; 21(18):1692-1709. PubMed ID: 33655862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of coumarin derivatives in pharmacotherapy of breast cancer.
    Musa MA; Cooperwood JS; Khan MO
    Curr Med Chem; 2008; 15(26):2664-79. PubMed ID: 18991629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy.
    Zhu S; Zhu W; Zhao K; Yu J; Lu W; Zhou R; Fan S; Kong W; Yang F; Shan P
    Cell Commun Signal; 2024 Jul; 22(1):361. PubMed ID: 39010083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
    Sashidhara KV; Avula SR; Sharma K; Palnati GR; Bathula SR
    Eur J Med Chem; 2013 Feb; 60():120-7. PubMed ID: 23287057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coumarin derivatives with anticancer activities: An update.
    Song XF; Fan J; Liu L; Liu XF; Gao F
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
    Elshemy HAH; Zaki MA
    Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.
    G AC; Gondru R; Li Y; Banothu J
    Eur J Med Chem; 2022 Jan; 227():113921. PubMed ID: 34715585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-breast cancer potential of indole/isatin hybrids.
    Wang R; Huang R; Yuan Y; Wang Z; Shen K
    Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300402. PubMed ID: 37650315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
    Dandriyal J; Singla R; Kumar M; Jaitak V
    Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
    Emami S; Dadashpour S
    Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
    Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
    Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Antitumor Evaluation of Some Hybrid Molecules Containing Coumarin and Quinolinone Moieties.
    Rizzk YW; El-Deen IM; Mohammed FZ; Abdelhamid MS; Khedr AIM
    Anticancer Agents Med Chem; 2019; 19(16):2010-2018. PubMed ID: 31566140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coumarins: old compounds with novel promising therapeutic perspectives.
    Riveiro ME; De Kimpe N; Moglioni A; Vázquez R; Monczor F; Shayo C; Davio C
    Curr Med Chem; 2010; 17(13):1325-38. PubMed ID: 20166938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
    Yu H; Hou Z; Tian Y; Mou Y; Guo C
    Eur J Med Chem; 2018 May; 151():434-449. PubMed ID: 29649740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Literature Review on Coumarin Hybrids as Potential Anticancer Agents.
    Shaik BB; Katari NK; Seboletswe P; Gundla R; Kushwaha ND; Kumar V; Singh P; Karpoormath R; Bala MD
    Anticancer Agents Med Chem; 2023; 23(2):142-163. PubMed ID: 35440315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.